The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.
The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.
复制标题
阿尔茨海默氏病与APP相关的C99碎片调节细胞胆固醇的运输。
DOI:
10.15252/embj.2019103791
复制
发表时间:
2020-10-15
期刊:
影响因子:
--
通讯作者:
Area-Gomez E
中科院分区:
文献类型:
--
作者:
Montesinos J;Pera M;Larrea D;Guardia-Laguarta C;Agrawal RR;Velasco KR;Yun TD;Stavrovskaya IG;Xu Y;Koo SY;Snead AM;Sproul AA;Area-Gomez E
The link between cholesterol homeostasis and cleavage of the amyloid precursor protein (APP), and how this relationship relates to Alzheimer's disease (AD) pathogenesis, is still unknown. Cellular cholesterol levels are regulated through crosstalk between the plasma membrane (PM), where most cellular cholesterol resides, and the endoplasmic reticulum (ER), where the protein machinery that regulates cholesterol levels resides. The intracellular transport of cholesterol from the PM to the ER is believed to be activated by a lipid‐sensing peptide(s) in the ER that can cluster PM‐derived cholesterol into transient detergent‐resistant membrane domains (DRMs) within the ER, also called the ER regulatory pool of cholesterol. When formed, these cholesterol‐rich domains in the ER maintain cellular homeostasis by inducing cholesterol esterification as a mechanism of detoxification while attenuating its de novo synthesis. In this manuscript, we propose that the 99‐aa C‐terminal fragment of APP (C99), when delivered to the ER for cleavage by γ‐secretase, acts as a lipid‐sensing peptide that forms regulatory DRMs in the ER, called mitochondria‐associated ER membranes (MAM). Our data in cellular AD models indicates that increased levels of uncleaved C99 in the ER, an early phenotype of the disease, upregulates the formation of these transient DRMs by inducing the internalization of extracellular cholesterol and its trafficking from the PM to the ER. These results suggest a novel role for C99 as a mediator of cholesterol disturbances in AD, potentially explaining early hallmarks of the disease. When delivered to the ER, the C‐terminal BACE1 cleavage product of amyloid precursor protein APP acts as lipid‐sensing peptide, facilitating formation of detergent‐resistant mitochondria‐associated ER membranes (MAM) via internalization and retrograde transport of cholesterol.